Bulletin

Bulletin: Cancer vaccines: getting ready for a decade of big breakthroughs and novel treatments

Hear from leading industry experts in this emerging field who discuss: challenges related to antigen and adjuvant selection, vaccine design, immune response improvement and future treatment options.

Frost & Sullivan recently invited industry leaders in cancer vaccine research to participate in a new and unique thought leadership forum. This forum discussed challenges related to antigen and adjuvant selection, vaccine design, immune response improvement and future treatment options.